WILMINGTON, Del., July 29, 2024 /PRNewswire/ — DuPont (NYSE: DD) today announced that it has completed the previously announced acquisition of Donatelle Plastics (“Donatelle”), a leading medical device company specializing in medical components and devices.
“I’m pleased to welcome the talented Donatelle colleagues to DuPont,” said Jon Kemp, President, DuPont Electronics & Industrial (E&I). “We’re excited to add Donatelle’s best-in-class advanced injection molding manufacturing capabilities, and decades-long customer relationships with large medical device equipment manufacturers to E&I’s healthcare offerings.”
With a workforce of more than 400 employees, Donatelle becomes part of the Industrial Solutions line of business within the Electronics & Industrial segment. The acquisition of Donatelle brings complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building. Donatelle has a strong growth profile with offerings aligned to attractive therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.
SOURCE DuPont
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…
MESA, Ariz., Dec. 29, 2025 /PRNewswire/ -- Tri-City Cardiology's Ambulatory Surgical Center (ASC), legally referred to…
Collaborative AI-First Ventures Delivers Impactful Solutions for Health, Energy, Small Business and Enterprise SectorsLAS VEGAS,…
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…
Black Book Market Research issues a global operational alert alongside the release of its 2026…
The leader in sports medicine healing innovations worked with athletes, athletic trainers, physicians and foundations…